Foscarnet
فوسکارنت
🦠 Antiinfectives For Systemic UseAntiviral (pyrophosphate analogue)
Market / country: 🇺🇸 USA
Foscavir (US)
🧮 Dose calculator
Cytomegalovirus (CMV) — retinitis and transplant prophylaxis · Regimen source: FDA Foscavir · Dosage and Administration
🛡️ Safety & information
Contraindications
- ⛔ Clinically significant hypersensitivity to foscarnet. FDA Foscavir · Contraindications
Warnings
- • Boxed warning: renal impairment (major dose-limiting toxicity); mineral/electrolyte disturbances (calcium, magnesium) and seizures. FDA Foscavir · Boxed Warning
Formulations
- 24 mg/mL (250 mL) — injection 🇺🇸 USA FDA Foscavir · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Foscavir · Pregnancy
“Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Foscavir · Nursing Mothers
“Because of the potential for serious adverse events in nursing infants, a decision should be made whether to discontinue nursing or discontinue drug, taking into consideration the importance of the drug to the mother.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Foscavir · Pediatric Use
“The safety and effectiveness of FOSCAVIR in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Foscavir · Geriatric Use
“Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and renal function should be monitored.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA020068
- DailyMed (FDA label)FDA Foscavir
- MedlinePlus (NIH)Foscarnet Injection
- WHO ATC/DDDJ05AD01
- Darooyab (Iran)Foscarnet
🇮🇷 Registered in Iran Darooyab · G-1176/Foscarnet
Dosage forms with Iranian generic codes, per Darooyab.
- 07111 · FOSCARNET 24MG/ML 250ML INJ · فرآورده تزریقی فوسکارنت ۲۴ میلیگرم / میلیلیتر ۲۵۰ میلیلیتر
- 52426 · FOSCARNET SODIUM INJECTION, SOLUTION PARENTERAL 24 mg/1mL 250 mL · محلول تزریقی فوسکارنت سدیم ۲۴ میلیگرم / ۱ میلیلیتر ۲۵۰ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Foscavir · How SuppliedFDA Foscavir · Dosage and AdministrationFDA Foscavir · ContraindicationsFDA Foscavir · Boxed WarningFDA Foscavir · SPL approval / marketing categoryFDA Foscavir · PregnancyFDA Foscavir · Nursing MothersFDA Foscavir · Pediatric UseFDA Foscavir · Geriatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1176/Foscarnet
- Clinical review⚠ Unverified